News for 'Dr Reddy'

Investors' wealth rises Rs 5.66 lakh crore as equity markets rebound

Investors' wealth rises Rs 5.66 lakh crore as equity markets rebound

Rediff.com4 Oct 2022

Equity investors became richer by Rs 5.66 lakh crore as markets bounced back sharply on Tuesday following a recovery in global equities. The 30-share BSE Sensex jumped 1,276.66 points or 2.25 per cent to settle at 58,065.47 points. During the day, it zoomed 1,311.13 points or 2.30 per cent to 58,099.94 points. The market capitalisation of BSE-listed firms climbed Rs 566,318.84 crore to Rs 273,92,739.78 crore.

Sensex pares losses; finally ends down 581 pts on weak global cue

Sensex pares losses; finally ends down 581 pts on weak global cue

Rediff.com27 Jan 2022

HCL Tech was the top loser in the Sensex pack, skidding over 4 per cent, followed by Tech Mahindra Dr Reddy's, Wipro, TCS, Titan and Infosys. NSE Nifty plunged 167.80 points to 17,110.15.

Sensex pares early gains as IT stocks crack

Sensex pares early gains as IT stocks crack

Rediff.com9 Dec 2022

Equity benchmark Sensex declined nearly 390 points on Friday, pressured by heavy selling in IT, tech and energy stocks despite a positive trend in the global markets. Besides, rising crude oil prices and relentless foreign capital outflows further weighed on sentiment, traders said. The 30-share BSE Sensex opened strong but came under severe selling pressure to close 389.01 points or 0.62 per cent lower at 62,181.67.

Ranji: Sindhu's 11-wkt haul powers Haryana to victory

Ranji: Sindhu's 11-wkt haul powers Haryana to victory

Rediff.com8 Nov 2024

Punjab, starting the penultimate day on 73/3 and needing 144 more runs, crumbled under pressure from Sindhu's relentless spin and Jayant Yadav's precise off-spin (3/35 in 10.4 overs), collapsing well before lunch and handing Haryana their second outright win in four matches.

India witnessing fastest rise in cancer cases: Report

India witnessing fastest rise in cancer cases: Report

Rediff.com5 Apr 2024

On average, at least one in three Indians today were pre-diabetic, two in three were pre-hypertensive and one in 10 were depressed, the 4th edition of Apollo Hospitals' flagship Health of Nation Report on World Health Day 2024, said.

Teva sues Indian pharma cos

Teva sues Indian pharma cos

Rediff.com4 Jul 2007

Teva Pharmaceutical Industries Ltd has sued Indian drug makers, including Ranbaxy Laboratories and Dr Reddy's, for alleged patent violation of ingredients used in Coreg, used for treatment of cardiovascular diseases.

Electoral bonds: Who is lottery king Santiago Martin?

Electoral bonds: Who is lottery king Santiago Martin?

Rediff.com15 Mar 2024

Future Gaming and Hotel Services whose director is the lottery magnate Santiago Martin is the top purchaser of electoral bonds having purchased bonds worth Rs 1,368, according to data uploaded by the Election Commission of India on its website on Thursday.

Jayalalithaa's death: TN panel indicts Sasikala, govt prepares for action

Jayalalithaa's death: TN panel indicts Sasikala, govt prepares for action

Rediff.com18 Oct 2022

The Justice A Arumughaswamy Commission of Inquiry that probed the circumstances leading to Jayalalithaa's death in 2016, in its concluding remarks said that V K Sasikala, the late Chief Minister's confidante, 'have to be found fault with and investigation is to be ordered'.

Hasina in shock, govt giving her time: Jaishankar

Hasina in shock, govt giving her time: Jaishankar

Rediff.com6 Aug 2024

Jaishankar briefed the leaders of all parties about the situation in the violence-hit nation and the steps taken by the Indian government.

'Our risk is now being managed'

'Our risk is now being managed'

Rediff.com10 Mar 2006

The US continues to be the most important part of our overseas portfolio

DRL develops generic version of Lipitor

DRL develops generic version of Lipitor

Rediff.com7 Nov 2009

Dr Reddy's Laboratories has succeeded in developing a copycat or generic version of Pfizer's Lipitor, the world's largest selling drug which has sales of over $10 billion.

'Only A Very Rich Man Can Stand For Elections'

'Only A Very Rich Man Can Stand For Elections'

Rediff.com8 May 2024

'All my wealth I earned in the US. It is all money earned transparently. I have paid all taxes.'

Sensex, Nifty rebound sharply after 4-day rout

Sensex, Nifty rebound sharply after 4-day rout

Rediff.com8 Mar 2022

From the 30-share pack, Sun Pharma, TCS, Tech Mahindra, NTPC, Wipro, UltraTech Cement, Dr Reddy's Laboratories and Infosys were the major gainers, jumping up to 3.99 per cent. In contrast, Tata Steel, Nestle, Titan Company, PowerGrid, Reliance Industries Limited and State Bank of India were among the laggards.

RIL, ITC, Kotak Bank drag Sensex down by 166 points

RIL, ITC, Kotak Bank drag Sensex down by 166 points

Rediff.com14 Dec 2021

ITC was the top loser in the Sensex pack, shedding nearly 3 per cent, followed by Bajaj Finance, Kotak Bank, Bharti Airtel and Reliance Industries. Nifty fell 43.35 points to 17,324.90.

Sensex tanks 202 pts as Covid surge continued to weigh on investors sentiments

Sensex tanks 202 pts as Covid surge continued to weigh on investors sentiments

Rediff.com23 Apr 2021

M&M was the top loser in the Sensex pack, shedding over 2 per cent, followed by Dr Reddy's Bharti Airtel, Tech Mahindra, HUL, ICICI Bank and Infosys. NSE Nifty dropped 64.80 points to 14,341.35.

Pharma majors shift slect production to India

Pharma majors shift slect production to India

Rediff.com28 May 2007

After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddy's Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to their Indian facilities.

'Oil remains a concern'

'Oil remains a concern'

Rediff.com21 Oct 2004

Otherwise markets would be okay..

Sensex gains 345 points at close; FMCG, auto shares shine

Sensex gains 345 points at close; FMCG, auto shares shine

Rediff.com15 Jul 2022

Benchmark BSE Sensex rebounded by 344 points while Nifty closed above the 16,000 level in choppy trade on Friday, snapping the four-day falling streak on renewed buying interest from foreign funds and firm global trends. The 30-share BSE barometer climbed 344.63 points or 0.65 per cent to settle at 53,760.78. During the day, it jumped 395.22 points or 0.73 per cent to 53,811.37.

Sensex sinks 486 pts led by losses in index majors

Sensex sinks 486 pts led by losses in index majors

Rediff.com8 Jul 2021

Tata Steel was the top loser in the Sensex pack, shedding over 2 per cent, followed by Sun Pharma, ICICI Bank, SBI, Kotak Bank and Dr Reddy's. NSE Nifty dropped 151.75 points to 15,727.90.

Markets settle marginally higher on fag-end buying

Markets settle marginally higher on fag-end buying

Rediff.com18 Aug 2022

Equity benchmark Sensex gained 37 points on Thursday, tracking gains in index majors Kotak Bank, L&T and Bharti Airtel amid a largely negative trend in global markets. After a largely choppy session, the 30-share BSE index ended 37.87 points or 0.06 per cent higher at 60,298 after starting the trade on a weak note. During the day, it hit a high of 60,341.41 and a low of 59,946.44.

Sensex, Nifty end in red on profit booking

Sensex, Nifty end in red on profit booking

Rediff.com4 Aug 2022

Equity benchmarks snapped their six-session rally to close marginally lower on Thursday amid profit booking in banking and energy counters. Investors also stayed on the sidelines ahead of the RBI's policy meet outcome on Friday. In choppy trade, the 30-share BSE Sensex ended 51.73 points or 0.09 per cent lower at 58,298.80. During the day, it hit a low of 57,577.05 and a high of 58,712.66.

Markets rally for 2nd day; Sensex jumps 1,041 points

Markets rally for 2nd day; Sensex jumps 1,041 points

Rediff.com28 Jul 2022

Benchmark indices rallied on Thursday with the Sensex and Nifty climbing nearly 2 per cent, helped by heavy buying in Bajaj Finance shares amid a mixed trend in the global equity markets. The 30-share BSE benchmark jumped 1,041.47 points or 1.87 per cent to settle at 56,857.79. During the day, it rallied 1,097.9 points or 1.96 per cent to 56,914.22. The broader NSE Nifty advanced 287.80 points or 1.73 per cent to 16,929.60.

Excise policy: ED arrests BRS leader Kavitha after raid; taken to Delhi

Excise policy: ED arrests BRS leader Kavitha after raid; taken to Delhi

Rediff.com15 Mar 2024

BRS leader and former Telangana minister Vemula Prashanth Reddy claimed that Kavitha was taken to Delhi on a flight at 8.45 pm.

Sensex climbs 284 points to settle at 55,682

Sensex climbs 284 points to settle at 55,682

Rediff.com21 Jul 2022

Benchmark indices bounced back after falling in early trade on Thursday and logged the fifth day of gain amid a decline in crude oil prices and foreign funds inflow. The 30-share BSE Sensex climbed 284.42 points or 0.51 per cent to settle at 55,681.95. During the day, it jumped 340.96 points or 0.61 per cent to 55,738.49. The broader NSE Nifty went higher by 84.40 points or 0.51 per cent to 16,605.25.

Sensex ends flat in cautious trade

Sensex ends flat in cautious trade

Rediff.com20 Sep 2017

Among major gainers, ITC, Reliance Industries, Dr Reddy's and HDFC rose up to 3 per cent.

IT, oil, banking shares boost Sensex by 760 points

IT, oil, banking shares boost Sensex by 760 points

Rediff.com18 Jul 2022

Benchmark stock indices Sensex and Nifty spurted over 1 per cent at close on Monday following buying in IT, oil and gas and banking shares bolstered by firm global trends. Rising for a second straight session, the 30-share BSE Sensex rallied 760.37 points or 1.41 per cent to settle at 54,521.15. During the day, it jumped 795.88 points or 1.48 per cent to 53,760.78. The broader NSE Nifty advanced 229.30 points or 1.43 per cent to 16,278.50 as 41 of its constituents advanced.

Sarfaraz's First Reaction To India Call

Sarfaraz's First Reaction To India Call

Rediff.com30 Jan 2024

Sarfaraz's inclusion is well-deserved, backed by an exceptional performance in the unofficial Test match against England Lions,

Full list: Modi's New Ministers And Their Portfolios

Full list: Modi's New Ministers And Their Portfolios

Rediff.com10 Jun 2024

Here is the complete list of ministers in Modi 3.0 and their portfolios:

Be a Medical Representative

Be a Medical Representative

Rediff.com11 May 2005

Dr Reddy's Laboratories, a global pharma company, is hiring Medical Representatives.

Sensex falls 111 points; RIL tumbles over 7%

Sensex falls 111 points; RIL tumbles over 7%

Rediff.com1 Jul 2022

Benchmark indices settled lower on Friday, with the Sensex declining 111 points on the back of a sharp fall in index heavyweight Reliance Industries. The BSE benchmark went lower by 111.01 points or 0.21 per cent to settle at 52,907.93. During the day, it tanked 924.69 points or 1.74 per cent to 52,094.25. The NSE Nifty dipped 28.20 points or 0.18 per cent to close at 15,752.05.

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

Rediff.com11 Apr 2021

These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.

Why Did TN Governor Omit Dr Ambedkar's Name?

Why Did TN Governor Omit Dr Ambedkar's Name?

Rediff.com10 Jan 2023

According to state government sources, not only did the governor insert some corrections, but he also initialled the final draft after those corrections had been made, reveals N Sathiya Moorthy.

Realty, auto, metal stocks drag Sensex down by 550 points

Realty, auto, metal stocks drag Sensex down by 550 points

Rediff.com18 Jan 2022

Equity benchmark Sensex plunged by 554.05 points on Tuesday, tracking deep losses in realty, auto and metal stocks amid widespread selling pressure in global markets. The 30-share index slumped by 554.05 points or 0.90 per cent to end at 60,754.86. The broader NSE Nifty fell by 195.05 points or 1.07 per cent to 18,113.05.

Sensex zoomed 934 points to settle at 52,532

Sensex zoomed 934 points to settle at 52,532

Rediff.com21 Jun 2022

Benchmark indices advanced for the second straight session on Tuesday, with the Sensex and Nifty jumping nearly 2 per cent each, mirroring a rally in global equity markets. Buying in index majors Reliance Industries and IT stocks buoyed the benchmarks. The BSE Sensex zoomed 934.23 points or 1.81 per cent to settle at 52,532.07. During the day, it rallied 1,201.56 points or 2.32 per cent to 52,799.40. The NSE Nifty climbed 288.65 points or 1.88 per cent to finish at 15,638.80.

Pharma sector seeks boost to research, innovation

Pharma sector seeks boost to research, innovation

Rediff.com3 Jul 2014

Pharma firms wants new policies that will boost investment.

Pharma sector seeks boost to research, innovation

Pharma sector seeks boost to research, innovation

Rediff.com3 Jul 2014

Pharma firms wants new policies that will boost investment.

Sensex, Nifty advance on gains in IT, FMCG stocks

Sensex, Nifty advance on gains in IT, FMCG stocks

Rediff.com15 Nov 2021

Stock market barometers Sensex and Nifty ended marginally higher on Monday as rise in wholesale inflation capped early gains despite a positive trend in global markets. The 30-share index settled 32.02 points or 0.05 per cent higher at 60,718.71 with half of its constituents ending in green. The broad based Nifty edged up 6.70 points or 0.04 per cent to close at 18,109.45.

DRL to showcase new findings in US

DRL to showcase new findings in US

Rediff.com14 Jun 2003